# S9626: Megestrol in Treating Hot Flashes Following Treatment for Breast Cancer

> **NCT00005975** · PHASE3 · COMPLETED · sponsor: **SWOG Cancer Research Network** · enrollment: 288 (actual)

## Conditions studied

- Breast Cancer
- Hot Flashes

## Interventions

- **DRUG:** Megestrol Acetate 20mg/day
- **DRUG:** Megestrol Acetate 40 mg/day
- **DRUG:** Megestrol Acetate Placebo 20 mg/day
- **DRUG:** Megestrol Acetate Placebo 40 mg/day

## Key facts

- **NCT ID:** NCT00005975
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-04
- **Primary completion:** 2001-09
- **Final completion:** 2002-03
- **Target enrollment:** 288 (ACTUAL)
- **Last updated:** 2015-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005975, "S9626: Megestrol in Treating Hot Flashes Following Treatment for Breast Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00005975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*